Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of Eosinophilia in Asthma—New Therapeutic Approaches for Asthma Treatment
Ruth P. Cusack, Christiane E. Whetstone, Yanqing Xie, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 817-817
Open Access | Times Cited: 21

Showing 21 citing articles:

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma
Corrado Pelaia, Giulia Pelaia, Federico Longhini, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1108-1108
Open Access | Times Cited: 34
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2181-2181
Open Access | Times Cited: 25
Regulation of eosinophil recruitment and heterogeneity during allergic airway inflammation
Lukas Graf, Daniel Radtke, David Voehringer
Frontiers in Allergy (2025) Vol. 6
Open Access
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W. Busse, Peter Howarth, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2589-2604
Open Access | Times Cited: 3
Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma
Jolita Palačionytė, Andrius Januškevičius, Egle Vasyle, et al.
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1345-1345
Open Access | Times Cited: 1
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
Ian Pavord, Robert Chan, Nicola Brown, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
The impact of Charcot-Leyden Crystal protein on mesothelioma chemotherapy: targeting eosinophils for enhanced chemosensitivity
M. Willems, Malik Hamaïdia, Alexis Fontaine, et al.
EBioMedicine (2024) Vol. 109, pp. 105418-105418
Open Access | Times Cited: 1
Hydrogen Gas Inhalation Alleviates Airway Inflammation and Oxidative Stress on Ovalbumin-Induced Asthmatic BALB/c Mouse Model
Wenjing He, Md Habibur Rahman, Johny Bajgai, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1328-1328
Open Access | Times Cited: 1
B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis
Chrong‐Reen Wang, Yi‐Shan Tsai, Hung‐Wen Tsai, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4577-4577
Open Access | Times Cited: 10
Eosinophils, beyond IL-5
Stéphane Esnault, Mats W. Johansson, Sameer K. Mathur
Cells (2021) Vol. 10, Iss. 10, pp. 2615-2615
Open Access | Times Cited: 8
Antiasthmatic Compounds Targeting β2-Adrenergic Receptor from Perilla frutescens Improved Lung Inflammation by Inhibiting the NF-κB Signaling Pathway
Jing Wang, Qiuyu Gao, Shuangru Wan, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 11, pp. 2656-2666
Closed Access | Times Cited: 5
Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma
M. Willems, Arnaud Scherpereel, Eric Wasielewski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Dupilumab and Eosinophils: A Red Flag?
William W. Busse
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2710-2712
Open Access | Times Cited: 3
Anti-Inflammatory and Immunoregulatory Effects of Xiaoqinglong Decoction on a Murine Model of Combined Allergic Rhinitis and Asthma Syndrome
Jingyi Zhao, Xinyu Yan, Man Wang, et al.
Natural Product Communications (2024) Vol. 19, Iss. 8
Open Access
Asthma bronchiale
Florian Stellmacher, Sven Perner
Springer eBooks (2024), pp. 29-31
Closed Access
Unique effect of aspirin on local 15‐oxo‐eicosatetraenoic acid synthesis in asthma patients with aspirin hypersensitivity
Piotr Szatkowski, Anna Gielicz, Adam Stępień, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 12
Open Access
Refashioning dexpramipexole: A new horizon in eosinophilic asthma?
Ruth P. Cusack, Ibrahim Sulaiman, Gail M. Gauvreau
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 5, pp. 1092-1094
Open Access | Times Cited: 1
Cytokine Receptors and Their Ligands
Karen S. Cheung Tung Shing, Winnie L. Kan, Tracy L. Nero, et al.
Elsevier eBooks (2022), pp. 21-45
Closed Access | Times Cited: 2
Use of Asthma Medication During Gestation and Risk of Specific Congenital Anomalies
Ruth P. Cusack, Christiane E. Whetstone, Gail M. Gauvreau
Immunology and Allergy Clinics of North America (2022) Vol. 43, Iss. 1, pp. 169-185
Closed Access | Times Cited: 2
Anti-Interleukin Biologics for the treatment of the Atopic March Diseases
Nightingale Syabbalo
(2021), pp. 1-27
Open Access | Times Cited: 2
Asthma
Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya
(2023), pp. 59-89
Closed Access
Page 1

Scroll to top